HK1030552A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: HK1030552A1
Authority: HK; Hong Kong
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1998-02-06

Application number

HK01101617A

Other languages

English (en)

Inventor

Nikki Thoennes Brooks

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-06

Filing date

2001-03-06

Publication date

2001-05-11

2001-03-06 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-05-11 Publication of HK1030552A1 publication Critical patent/HK1030552A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HK01101617A 1998-02-06 2001-03-06 Pharmaceutical compositions HK1030552A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9802472.2A GB9802472D0 (en)	1998-02-06	1998-02-06	Pharmaceutical compositions
PCT/EP1999/000663 WO1999039691A2 (en)	1998-02-06	1999-02-04	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
HK1030552A1 true HK1030552A1 (en)	2001-05-11

Family

ID=10826520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK01101617A HK1030552A1 (en)	1998-02-06	2001-03-06	Pharmaceutical compositions

Country Status (39)

Country	Link
US (1)	US6641843B1 (xx)
EP (1)	EP1051156B1 (xx)
JP (1)	JP3560550B2 (xx)
KR (1)	KR100564854B1 (xx)
CN (2)	CN1296406A (xx)
AP (1)	AP1212A (xx)
AR (1)	AR017455A1 (xx)
AT (1)	ATE237309T1 (xx)
AU (1)	AU754255B2 (xx)
BR (1)	BR9907649A (xx)
CA (1)	CA2319010C (xx)
CO (1)	CO5070673A1 (xx)
CZ (1)	CZ299608B6 (xx)
DE (1)	DE69906934T2 (xx)
DK (1)	DK1051156T3 (xx)
EA (1)	EA002916B1 (xx)
EE (1)	EE04217B1 (xx)
ES (1)	ES2196779T3 (xx)
GB (1)	GB9802472D0 (xx)
HK (1)	HK1030552A1 (xx)
HR (1)	HRP20000530B1 (xx)
HU (1)	HU228315B1 (xx)
ID (1)	ID26215A (xx)
IL (2)	IL137403A0 (xx)
IS (1)	IS2200B (xx)
MA (1)	MA26604A1 (xx)
MY (1)	MY121043A (xx)
NO (1)	NO329041B1 (xx)
NZ (1)	NZ505811A (xx)
PE (1)	PE20000271A1 (xx)
PL (1)	PL194558B1 (xx)
PT (1)	PT1051156E (xx)
RS (1)	RS49953B (xx)
SI (1)	SI1051156T1 (xx)
SK (1)	SK284397B6 (xx)
TR (1)	TR200002293T2 (xx)
TW (1)	TWI222878B (xx)
WO (1)	WO1999039691A2 (xx)
ZA (1)	ZA99890B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2080511A3 (en) *	2000-08-22	2009-09-30	Shire LLC	Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en)	2000-11-14	2013-03-12	Shire Llc	Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en)	2003-09-30	2007-01-30	New River Pharmaceuticals Inc.	Compounds and compositions for prevention of overdose of oxycodone
EP2085397A1 (en)	2008-01-21	2009-08-05	Esteve Quimica, S.A.	Crystalline form of abacavir
EP2305680A3 (en) *	2009-09-30	2011-05-18	Aurobindo Pharma Limited	Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
CN104788451A (zh) *	2014-01-21	2015-07-22	浙江九洲药业股份有限公司	一种阿巴卡韦的制备方法
CN105315280A (zh) *	2014-06-06	2016-02-10	上海迪赛诺化学制药有限公司	一种阿巴卡韦结晶体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5567703A (en)	1988-01-20	1996-10-22	Regents Of The University Of Minnesota	Method for treating HIV infections with dideoxycarbocyclic nucleosides
US5631370A (en)	1988-01-20	1997-05-20	Regents Of The University Of Minnesota	Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
MY104575A (en) *	1989-12-22	1994-04-30	The Wellcome Foundation Ltd	Therapeutic nucleosides.
GB9417249D0 (en) *	1994-08-26	1994-10-19	Wellcome Found	A novel salt
IL127350A0 (en) *	1996-06-25	1999-10-28	Glaxo Group Ltd	Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
US6124319A (en) *	1997-01-21	2000-09-26	Merck & Co., Inc.	3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6177464B1 (en) *	1997-03-14	2001-01-23	Sepracor, Inc.	Ring opening metathesis of alkenes
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt

1998
- 1998-02-06 GB GBGB9802472.2A patent/GB9802472D0/en not_active Ceased
1999
- 1999-02-02 TW TW088101534A patent/TWI222878B/zh not_active IP Right Cessation
- 1999-02-03 PE PE1999000088A patent/PE20000271A1/es not_active IP Right Cessation
- 1999-02-03 AR ARP990100439A patent/AR017455A1/es active IP Right Grant
- 1999-02-04 WO PCT/EP1999/000663 patent/WO1999039691A2/en active IP Right Grant
- 1999-02-04 TR TR2000/02293T patent/TR200002293T2/xx unknown
- 1999-02-04 HU HU0100802A patent/HU228315B1/hu unknown
- 1999-02-04 SK SK1168-2000A patent/SK284397B6/sk not_active IP Right Cessation
- 1999-02-04 DK DK99907477T patent/DK1051156T3/da active
- 1999-02-04 KR KR1020007008595A patent/KR100564854B1/ko not_active IP Right Cessation
- 1999-02-04 EA EA200000736A patent/EA002916B1/ru not_active IP Right Cessation
- 1999-02-04 EP EP99907477A patent/EP1051156B1/en not_active Expired - Lifetime
- 1999-02-04 AT AT99907477T patent/ATE237309T1/de active
- 1999-02-04 IL IL13740399A patent/IL137403A0/xx active IP Right Grant
- 1999-02-04 AP APAP/P/2000/001878A patent/AP1212A/en active
- 1999-02-04 US US09/601,671 patent/US6641843B1/en not_active Expired - Lifetime
- 1999-02-04 AU AU27221/99A patent/AU754255B2/en not_active Expired
- 1999-02-04 PT PT99907477T patent/PT1051156E/pt unknown
- 1999-02-04 ZA ZA9900890A patent/ZA99890B/xx unknown
- 1999-02-04 MY MYPI99000389A patent/MY121043A/en unknown
- 1999-02-04 SI SI9930271T patent/SI1051156T1/xx unknown
- 1999-02-04 CZ CZ20002867A patent/CZ299608B6/cs not_active IP Right Cessation
- 1999-02-04 ID IDW20001507A patent/ID26215A/id unknown
- 1999-02-04 PL PL99342628A patent/PL194558B1/pl unknown
- 1999-02-04 CO CO99006407A patent/CO5070673A1/es unknown
- 1999-02-04 NZ NZ505811A patent/NZ505811A/xx not_active IP Right Cessation
- 1999-02-04 DE DE69906934T patent/DE69906934T2/de not_active Expired - Lifetime
- 1999-02-04 CN CN99804843A patent/CN1296406A/zh active Pending
- 1999-02-04 RS YUP-482/00A patent/RS49953B/sr unknown
- 1999-02-04 BR BR9907649-7A patent/BR9907649A/pt not_active Application Discontinuation
- 1999-02-04 CN CNA2008100838827A patent/CN101239063A/zh active Pending
- 1999-02-04 EE EEP200000459A patent/EE04217B1/xx unknown
- 1999-02-04 CA CA002319010A patent/CA2319010C/en not_active Expired - Lifetime
- 1999-02-04 MA MA25452A patent/MA26604A1/fr unknown
- 1999-02-04 ES ES99907477T patent/ES2196779T3/es not_active Expired - Lifetime
- 1999-02-04 JP JP2000530191A patent/JP3560550B2/ja not_active Expired - Lifetime
2000
- 2000-07-19 IL IL137403A patent/IL137403A/en not_active IP Right Cessation
- 2000-07-20 IS IS5569A patent/IS2200B/is unknown
- 2000-08-04 HR HR20000530A patent/HRP20000530B1/xx not_active IP Right Cessation
- 2000-08-04 NO NO20003962A patent/NO329041B1/no not_active IP Right Cessation
2001
- 2001-03-06 HK HK01101617A patent/HK1030552A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
MA26604A1 (fr)	2004-12-20
SK284397B6 (sk)	2005-03-04
CZ299608B6 (cs)	2008-09-17
AP2000001878A0 (en)	2000-09-30
IL137403A (en)	2007-07-24
ES2196779T3 (es)	2003-12-16
PE20000271A1 (es)	2000-04-17
SK11682000A3 (sk)	2001-04-09
CN1296406A (zh)	2001-05-23
BR9907649A (pt)	2000-10-31
AU2722199A (en)	1999-08-23
HRP20000530A2 (en)	2001-02-28
HUP0100802A3 (en)	2001-12-28
CN101239063A (zh)	2008-08-13
GB9802472D0 (en)	1998-04-01
WO1999039691A3 (en)	1999-10-28
CA2319010C (en)	2008-06-10
EP1051156A2 (en)	2000-11-15
KR20010040714A (ko)	2001-05-15
AP1212A (en)	2003-11-12
ATE237309T1 (de)	2003-05-15
IS2200B (is)	2007-02-15
IS5569A (is)	2000-07-20
EP1051156B1 (en)	2003-04-16
DE69906934T2 (de)	2004-02-12
ZA99890B (en)	2000-08-04
PL194558B1 (pl)	2007-06-29
NO20003962D0 (no)	2000-08-04
AR017455A1 (es)	2001-09-05
EE200000459A (et)	2002-02-15
IL137403A0 (en)	2001-07-24
YU48200A (sh)	2003-02-28
KR100564854B1 (ko)	2006-03-30
DK1051156T3 (da)	2003-06-23
JP3560550B2 (ja)	2004-09-02
NO329041B1 (no)	2010-08-02
JP2002502808A (ja)	2002-01-29
US6641843B1 (en)	2003-11-04
TWI222878B (en)	2004-11-01
NO20003962L (no)	2000-09-27
CA2319010A1 (en)	1999-08-12
PL342628A1 (en)	2001-06-18
HRP20000530B1 (en)	2003-10-31
DE69906934D1 (de)	2003-05-22
EA002916B1 (ru)	2002-10-31
HU228315B1 (en)	2013-03-28
RS49953B (sr)	2008-09-29
ID26215A (id)	2000-12-07
MY121043A (en)	2005-12-30
PT1051156E (pt)	2003-09-30
SI1051156T1 (en)	2003-08-31
CZ20002867A3 (cs)	2001-02-14
EE04217B1 (et)	2004-02-16
CO5070673A1 (es)	2001-08-28
HUP0100802A2 (hu)	2001-08-28
EA200000736A1 (ru)	2001-04-23
NZ505811A (en)	2002-09-27
TR200002293T2 (tr)	2000-11-21
WO1999039691A2 (en)	1999-08-12
AU754255B2 (en)	2002-11-07

Publication	Publication Date	Title
HU9901606D0 (en)	1999-07-28	Pharmaceutical compositions
GB9827996D0 (en)	1999-02-10	Pharmaceutical Compositions
HUP0103507A3 (en)	2002-05-28	Pharmaceutical compositions comprising 2-quinolones
GB9727053D0 (en)	1998-02-18	Pharmaceutical compositions
PL343627A1 (en)	2001-08-27	Medicinal compositions
PT1466615E (pt)	2009-09-07	Composição farmacêutica
CY2569B1 (en)	2008-07-02	Pharmaceutical compositions
PL343769A1 (en)	2001-09-10	Pharmaceutical composition
GB9809213D0 (en)	1998-07-01	Pharmaceutical compositions
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
IL131995A0 (en)	2001-03-19	Gastric-retained pharmaceutical compositions
GB9723985D0 (en)	1998-01-14	Pharmaceutical compositions
HUP0004669A3 (en)	2005-03-29	Pharmaceutical compositions
EP1124557A4 (en)	2002-08-07	PHARMACEUTICAL COMPOSITION
HK1030552A1 (en)	2001-05-11	Pharmaceutical compositions
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9806487D0 (en)	1998-05-27	Pharmaceutical compositions
GB9921495D0 (en)	1999-11-17	Pharmaceutical compositions
HU9800078D0 (en)	1998-04-28	Pharmaceutical composition
GB9826822D0 (en)	1999-01-27	Pharmaceutical compositions
GB9814818D0 (en)	1998-09-09	Pharmaceutical compositions
GB9818953D0 (en)	1998-10-21	Pharmaceutical compositions
GB9827006D0 (en)	1999-02-03	Pharmaceutical compositions
GB9826821D0 (en)	1999-01-27	Pharmaceutical compositions
GB9827441D0 (en)	1999-02-10	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2019-02-22	PE	Patent expired	Effective date: 20190203